Exelixis
EXEL
#2017
Rank
โ‚ฌ7.41 B
Marketcap
25,80ย โ‚ฌ
Share price
-0.85%
Change (1 day)
29.85%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company